Technical Analysis for PRME - Prime Medicine, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Weak + Overbought | Other | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Shooting Star Candlestick | Bearish | 1.50% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 14 hours ago |
| Reversed from Up | about 17 hours ago |
| Gap Up Closed | about 17 hours ago |
| 60 Minute Opening Range Breakdown | about 17 hours ago |
| Fell Below Upper Bollinger Band | about 18 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Prime Medicine is a biotechnology company committed to delivering a new class of differentiated, one-time, curative genetic therapies to address the widest spectrum of diseases. The company is deploying Prime Editing technology, a versatile, precise, efficient and broad gene editing technology, which is designed to make only the right edit at the right position within a gene. With the theoretical potential to repair approximately 90 percent of known disease-causing genetic mutations across many organs and cell types, medicines based on Prime Editing, if approved, could offer a one-time curative genetic therapeutic option to a broad set of patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Emerging Technologies Molecular Biology Medical Genetics Genetic Engineering Gene Editing Gene Editing Technology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Emerging Technologies Molecular Biology Medical Genetics Genetic Engineering Gene Editing Gene Editing Technology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.195 |
| 52 Week Low | 4.11 |
| Average Volume | 726,590 |
| 200-Day Moving Average | 8.27 |
| 50-Day Moving Average | 6.14 |
| 20-Day Moving Average | 5.29 |
| 10-Day Moving Average | 5.87 |
| Average True Range | 0.54 |
| RSI (14) | 65.64 |
| ADX | 26.47 |
| +DI | 32.41 |
| -DI | 14.35 |
| Chandelier Exit (Long, 3 ATRs) | 5.55 |
| Chandelier Exit (Short, 3 ATRs) | 5.73 |
| Upper Bollinger Bands | 6.70 |
| Lower Bollinger Band | 3.89 |
| Percent B (%b) | 1.02 |
| BandWidth | 53.14 |
| MACD Line | 0.13 |
| MACD Signal Line | -0.13 |
| MACD Histogram | 0.2571 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.53 | ||||
| Resistance 3 (R3) | 7.56 | 7.35 | 7.40 | ||
| Resistance 2 (R2) | 7.35 | 7.15 | 7.33 | 7.35 | |
| Resistance 1 (R1) | 7.05 | 7.03 | 6.95 | 7.02 | 7.31 |
| Pivot Point | 6.84 | 6.84 | 6.78 | 6.82 | 6.84 |
| Support 1 (S1) | 6.54 | 6.64 | 6.44 | 6.51 | 6.21 |
| Support 2 (S2) | 6.33 | 6.52 | 6.31 | 6.17 | |
| Support 3 (S3) | 6.03 | 6.33 | 6.12 | ||
| Support 4 (S4) | 6.00 |
